Bioconjugation Is Quietly Redefining Precision Biology — And the Industry Is Finally Paying Attention
For years, bioconjugation was treated as a supporting technique—important, yes, but rarely the centerpiece of scientific discussion. That era is ending. As drug developers push toward more targeted, multifunctional, and tunable biomolecules, bioconjugation has moved from the periphery to the strategic core of modern biomedicine. The shift is not just technical; it reflects a broader...
0 Comments 0 Shares 38 Views 0 Reviews